Skip to main content
SpringerLink
Log in

BEAM-conditioned autologous SCT improves the quality of response in Waldenström’s macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre’s 10-year experience

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, France, 2008.

    Google Scholar 

  2. Treon SP How I treat Waldenstrom macroglobulinemia. Blood 2009; 114: 2375–2385.

    Article  CAS  PubMed  Google Scholar 

  3. Tam C, Seymour JF, Brown M, Campbell P, Scarlett J, Underhill C et al. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. Haematologica 2005; 90: 700–702.

    CAS  PubMed  Google Scholar 

  4. Dimopoulos MA, Hamilos G, Efstathiou E, Siapkaras I, Matsouka C, Gika D et al. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide. Leukemia Lymphoma 2003; 44: 993–996.

    Article  CAS  PubMed  Google Scholar 

  5. Tamburini J, Levy V, Chaleteix C, Fermand JP, Delmer A, Stalniewicz L et al. Fludarabine plus cyclophosphamide in Waldenstrom's macroglobulinemia: results in 49 patients. Leukemia 2005; 19: 1831–1834.

    Article  CAS  PubMed  Google Scholar 

  6. Owen RG, Kyle RA, Stone MJ, Rawstron AC, Leblond V, Merlini G et al. Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. Br J Haematol 2013; 160: 171–176.

    Article  PubMed  Google Scholar 

  7. Kyriakou C, Canals C, Sibon D, Cahn JY, Kazmi M, Arcese W et al. High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2010; 28: 2227–2232.

    Article  CAS  PubMed  Google Scholar 

  8. Caravita T, Siniscalchi A, Tendas A, Cupelli L, Dentamaro T, Natale G et al. High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia. Bone Marrow Transplant 2009; 43: 587–588.

    Article  CAS  PubMed  Google Scholar 

  9. Usmani S, Sexton R, Crowley J, Barlogie B . Autologous stem cell transplantation as a care option in Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma Leuk 2011; 11: 139–142.

    Article  PubMed  Google Scholar 

  10. Dimopoulos MA, Gertz MA, Kastritis E, Garcia-Sanz R, Kimby EK, Leblond V et al. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. J Clin Oncol 2009; 27: 120–126.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK

    M A V Marzolini, K J Thomson, J Dorman & S D'Sa

Authors
  1. M A V Marzolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K J Thomson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Dorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S D'Sa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M A V Marzolini.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marzolini, M., Thomson, K., Dorman, J. et al. BEAM-conditioned autologous SCT improves the quality of response in Waldenström’s macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre’s 10-year experience. Bone Marrow Transplant 49, 1231–1232 (2014). https://doi.org/10.1038/bmt.2014.113

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.113

  • Springer Nature Limited

This article is cited by

Search

Navigation